MolNFT v1 · #103720 · protein
Fab fragment of der P 1 specific antibody 10B9
4POZ · Light chain of Fab fragment of 10B9 antibody: “Fab fragment of der P 1 specific antibody 10B9”. X-ray diffraction, 5 pockets (best druggability 0.52). MolNFT v1 #103720 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4POZ
- Type
- protein
- Length
- 426 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Light chain of Fab fragment of 10B9 antibody; Heavy chain of Fab fragment of 10B9 antibody
- Pockets
- 5 · best druggability 0.52
Structure
x-ray diffraction · 2 distinct chains · 8% helix, 52% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| C | Light chain of Fab fragment of 10B9 antibody | protein | 211 | 6% helix, 51% strand | — |
| D | Heavy chain of Fab fragment of 10B9 antibody | protein | 215 | 9% helix, 53% strand | — |
Pockets
5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 319 | 0.52 | 0.74 | 40 | empty |
| 2 | 66 | 0.45 | 0.83 | 24 | empty |
| 3 | 100 | 0.36 | 0.74 | 18 | empty |
| 4 | 66 | 0.32 | 0.75 | 18 | empty |
| 5 | 55 | 0.28 | 0.74 | 17 | empty |
Interfaces
1 interface between chains.
- C–D · 1928 Ų buried · 16 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 disulfide (disulfide).
Compared structures
- 4POZ · Fab fragment of Der p 1 specific antibody 10B9 · the same entry in another collection · chain C against C, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 4POZ · PDBe 4POZ
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.